The health system and biotech company are collaborating to create a Covid-19 patient registry biobank, which will combine de-identified patient data and AI technology to identify characteristics and trends that have an impact on disease outcomes.
Mount Sinai Health System's new spinout company, Sema4, will rely on genomic and clinical data to better diagnose, treat and prevent diseases.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Even though some medical professionals associate addiction as a type of disease, neuroscientists say otherwise and explain that thinking of addiction as a disease doesn't help anyone.